GoAI
Get started
GlucoTrack, Inc. logo

GlucoTrack, Inc.

GCTK

NASDAQHealthcareMedical - Instruments & Supplies

Open in GoAI

Previous close

$0.3474

+$0.0058 · +1.70%

Aug 21, 4:00 PM ET

GCTK company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

43

Fair Value

Momentum

16

Strong Down

Sentiment

56

Mixed

Risk resilience

34

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
Headquarters
US
CEO
Erik Emerson
Listed since
Apr 25, 2013
Employees
15

Market position

Day range

Current $0.3474

52-week range

Current $0.3474

Open
$0.3378
Previous close
$0.3416
Volume
697.6K
0.07× average
Average volume
10.35M
Average daily volume
Market cap
2.68M USD
Beta
0.66
Market reference 1
50-day average
$0.3929
-11.58% below average
200-day average
$1.9772
-82.43% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
-0.03×
P/B (TTM)
-0.67×
P/S (TTM)
0×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
0.00%
Operating margin
0.00%
Net margin
0.00%

Financial health

Debt / equity
-0.01×

Financial statements

Income trends

Operating income

−16.09M USD-10.61%

Net income

−19.39M USD+14.20%
Income trends across reported periods−2.18M USD−9.61M USD−17.03M USD−24.45M USDOperating income, FY2021: −4.04M USDOperating income, FY2022: −4.43M USDOperating income, FY2023: −7.1M USDOperating income, FY2024: −14.55M USDOperating income, FY2025: −16.09M USDNet income, FY2021: −4.07M USDNet income, FY2022: −4.44M USDNet income, FY2023: −7.1M USDNet income, FY2024: −22.6M USDNet income, FY2025: −19.39M USDFY2021FY2022FY2023FY2024FY2025
Operating income FY2021 −4.04M USD. Operating income FY2022 −4.43M USD. Operating income FY2023 −7.1M USD. Operating income FY2024 −14.55M USD. Operating income FY2025 −16.09M USD. Net income FY2021 −4.07M USD. Net income FY2022 −4.44M USD. Net income FY2023 −7.1M USD. Net income FY2024 −22.6M USD. Net income FY2025 −19.39M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Research and development9.81M USD9.5M USD4.7M USD1.97M USD1.81M USD
Selling, general, and administrative6.28M USD5.05M USD2.4M USD2.45M USD2.12M USD
Operating expenses16.09M USD14.55M USD7.1M USD4.43M USD4.04M USD
Interest income—62K USD7K USD11K USD26K USD
Interest expense—628K USD—3K USD—
Depreciation and amortization42K USD36K USD13K USD23K USD42K USD
Operating income−16.09M USD−14.55M USD−7.1M USD−4.43M USD−4.04M USD
Net income−19.39M USD−22.6M USD−7.1M USD−4.44M USD−4.07M USD

Company facts updated Aug 24, 2026.

GCTK peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

Continue in GoAI

Research GCTK

research.disclaimer